Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 9/20 | 0.55 |
| ▸ | IKZF1 | Q13422 | 3/20 | 0.53 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.52 |
| ▸ | IKZF2 | Q9UKS7 | 7/20 | 0.49 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27216961 | 1.00 | CRBN (0.55) | CRBNIKZF1CSNK1A1IKZF2MAP1LC3B | |
| SCHEMBL27216923 | 0.90 | CRBN (0.56) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL30801574 | 0.90 | CRBN (0.56) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL27312418 | 0.89 | CRBN (0.55) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL30801575 | 0.88 | CRBN (0.53) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL27217199 | 0.87 | CRBN (0.53) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL27217070 | 0.87 | CRBN (0.53) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL27216986 | 0.86 | CRBN (0.56) | CRBNIKZF1CSNK1A1IKZF2 | |
| SCHEMBL27323246 | 0.85 | CRBN (0.52) | CRBNIKZF1CSNK1A1IKZF2MAP1LC3B | |
| SCHEMBL27312417 | 0.85 | CRBN (0.53) | CRBNIKZF1CSNK1A1IKZF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584259-A1 | CK1ALPHA AND DUAL CK1ALPHA / GSPT1 DEGRADING COMPOUNDS | Innovo Therapeutics, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054832-A1 | CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS | INNOVO THERAPEUTICS, INC. (US) | 2024-03-14 | — | — | WO | disclosed |